We are live on
!
Find out more
AAP
Ardsley Advisory Partners Portfolio holdings
AUM
$960M
1-Year Est. Return
207.76%
This Fund
S&P 500
This Quarter
Est. Return
-7.03%
1 Year Est. Return
+207.76%
3 Year Est. Return
+554.53%
5 Year Est. Return
+728.66%
10 Year Est. Return
+4,084.52%
AUM
$446M
AUM Growth
-$188M
(-30%)
Cap. Flow
-$138M
Cap. Flow
% of AUM
-31.01%
Top 10 Holdings %
Top 10 Hldgs %
45.39%
Holding
194
New
46
Increased
33
Reduced
32
Closed
61
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
+$17.1M |
| 2 |
Alibaba
BABA
|
+$13.8M |
| 3 |
JE
Just Energy Group Inc
JE
|
+$9.47M |
| 4 |
SMAR
Smartsheet Inc.
SMAR
|
+$7.86M |
| 5 |
Guardant Health
GH
|
+$7.05M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLP
Cantaloupe
CTLP
|
+$32.7M |
| 2 |
Elevance Health
ELV
|
+$26.7M |
| 3 |
Advanced Micro Devices
AMD
|
+$7.95M |
| 4 |
Adobe
ADBE
|
+$7.66M |
| 5 |
XLNX
Xilinx Inc
XLNX
|
+$7.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.57% |
| 2 | Industrials | 14.77% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 8.46% |
| 5 | Utilities | 6.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CYBR
76
PUT
DELISTED
CyberArk
CYBR
| $699K | 0.16% |
+7,000
| New | +$844K |
|
77
Neurocrine Biosciences
NBIX
$18.4B
| $676K | 0.15% |
+7,500
| New | +$701K |
|
78
Dell
DELL
$253B
| $674K | 0.15% |
+25,649
| New | +$680K |
|
79
Bio-Rad Laboratories Class A
BIO
$8.86B
| $665K | 0.15% |
+2,000
| New | +$652K |
|
|
COHR
80
DELISTED
Coherent Inc
COHR
| $615K | 0.14% |
+4,000
| New | +$578K |
|
|
PRAH
81
DELISTED
PRA Health Sciences, Inc.
PRAH
| $595K | 0.13% |
+6,000
| New | +$596K |
|
82
ServiceNow
NOW
$114B
| $584K | 0.13% |
11,500
-23,500
| -67% | -$1.28M |
|
83
PUT
CrowdStrike
CRWD
$185B
| $583K | 0.13% |
+40,000
| New | +$794K |
|
84
STMicroelectronics
STM
$44.7B
| $580K | 0.13% |
+30,000
| New | +$550K |
|
|
VTNR
85
DELISTED
Vertex Energy, Inc
VTNR
| $571K | 0.13% |
504,306
| – | – |
|
86
MKS Inc
MKSI
$19.3B
| $554K | 0.12% |
+6,000
| New | +$496K |
|
|
NEWR
87
DELISTED
New Relic, Inc.
NEWR
| $553K | 0.12% |
+9,000
| New | +$651K |
|
88
PUT
Ciena
CIEN
$49.6B
| $549K | 0.12% |
+14,000
| New | +$587K |
|
89
Merck
MRK
$326B
| $547K | 0.12% |
6,812
-524
| -7% | -$42K |
|
|
AZRE
90
DELISTED
Azure Power Global Limited
AZRE
| $538K | 0.12% |
44,802
+24,802
| +124% | +$268K |
|
91
Celsius Holdings
CELH
$7.53B
| $521K | 0.12% |
+450,000
| New | +$626K |
|
|
XLNX
92
DELISTED
Xilinx Inc
XLNX
| $480K | 0.11% |
5,000
-69,500
| -93% | -$7.6M |
|
|
AMRS
93
CALL
DELISTED
Amyris Inc.
AMRS
| $476K | 0.11% |
+100,000
| New | +$373K |
|
94
ADMA Biologics
ADMA
$2.04B
| $474K | 0.11% |
106,500
+3,892
| +4% | +$16.3K |
|
95
Eli Lilly
LLY
$1.09T
| $447K | 0.1% |
4,000
-4,500
| -53% | -$501K |
|
96
Baxter International
BAX
$12.6B
| $437K | 0.1% |
+5,000
| New | +$427K |
|
|
IPHI
97
DELISTED
INPHI CORPORATION
IPHI
| $427K | 0.1% |
+7,000
| New | +$427K |
|
98
Cerus
CERS
$585M
| $412K | 0.09% |
80,000
| – | – |
|
99
FIVE9
FIVN
$2.08B
| $403K | 0.09% |
7,500
-1,500
| -17% | -$84.4K |
|
100
Vistra
VST
$50.1B
| $401K | 0.09% |
+15,000
| New | +$357K |
|
Similar funds
NA
MK
QIM
JVBC
TFP
UWPG
LOAMU
PHS
Ardsley Advisory Partners's Q3 2019 Portfolio in Review
As of Q3 2019, Ardsley Advisory Partners held 194 positions worth $446M, down 30% from $634M the previous quarter. Its ten largest holdings account for 45% of the portfolio.
Ardsley Advisory Partners withdrew a net $138M in Q3 2019, closing 61 positions and reducing 32 holdings. Its most notable exit was Cantaloupe, an estimated $32.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 30% a quarter earlier, followed by Industrials and Healthcare.
Against the trend, Ardsley Advisory Partners opened a new position in Alibaba worth $13.4M.
- Ardsley Advisory Partners's largest Q3 2019 buy was Alibaba: 80,250 shares worth $13.4M.
- Ardsley Advisory Partners added most to Biohaven Pharmaceutical Holding Company Ltd. in Q3 2019, an estimated $17.1M increase.
- Ardsley Advisory Partners's biggest Q3 2019 reduction was Advanced Micro Devices, cutting an estimated $7.95M.
- Ardsley Advisory Partners fully exited Cantaloupe in Q3 2019, selling an estimated $32.7M.
- Ardsley Advisory Partners's ten largest holdings make up 45% of its $446M portfolio in Q3 2019.
- Ardsley Advisory Partners opened 46 new positions and closed 61 in Q3 2019.
- Ardsley Advisory Partners's portfolio value fell 30% quarter-over-quarter to $446M.
Based on Ardsley Advisory Partners's 13F filing for Q3 2019, filed 14 Nov 2019.